These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25703643)

  • 1. Adjunctive treatment with melatonin receptor agonists for older delirious patients with the sundowning phenomenon.
    Yeh TC; Yeh CB; Tzeng NS; Mao WC
    J Psychiatry Neurosci; 2015 Mar; 40(2):E25-6. PubMed ID: 25703643
    [No Abstract]   [Full Text] [Related]  

  • 2. Melatonin receptor agonists for treating delirium in elderly patients with acute stroke.
    Ohta T; Murao K; Miyake K; Takemoto K
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1107-10. PubMed ID: 23017429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successfully treated delirium in an extremely elderly patient by switching from risperidone to ramelteon.
    Tsuda A; Nishimura K; Naganawa E; Otsubo T; Ishigooka J
    Psychiatry Clin Neurosci; 2013 Feb; 67(2):130. PubMed ID: 23438172
    [No Abstract]   [Full Text] [Related]  

  • 4. Emerging Role of Melatonin and Melatonin Receptor Agonists in Sleep and Delirium in Intensive Care Unit Patients.
    Mo Y; Scheer CE; Abdallah GT
    J Intensive Care Med; 2016 Aug; 31(7):451-5. PubMed ID: 26092575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ramelteon as adjunctive therapy for delirium referred to a consultation-liaison psychiatry service: a retrospective analysis.
    Furuya M; Miyaoka T; Yasuda H; Wake R; Hashioka S; Miura S; Nagahama M; Araki T; Horiguchi J
    Int J Geriatr Psychiatry; 2015 Sep; 30(9):994-5. PubMed ID: 26220878
    [No Abstract]   [Full Text] [Related]  

  • 6. Melatonin Receptor Agonists for Delirium Prevention.
    Walker CK; Gales MA
    Ann Pharmacother; 2017 Jan; 51(1):72-78. PubMed ID: 27539735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Therapy With Ramelteon for Hypoactive Delirium: A Case Report.
    Miura S; Furuya M; Yasuda H; Miyaoka T; Horiguchi J
    J Clin Psychopharmacol; 2015 Oct; 35(5):616-8. PubMed ID: 26114404
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of delirium with ramelteon: initial experience in three patients.
    Kimura R; Mori K; Kumazaki H; Yanagida M; Taguchi S; Matsunaga H
    Gen Hosp Psychiatry; 2011; 33(4):407-9. PubMed ID: 21762839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked improvement in delirium with ramelteon: five case reports.
    Furuya M; Miyaoka T; Yasuda H; Yamashita S; Tanaka I; Otsuka S; Wake R; Horiguchi J
    Psychogeriatrics; 2012 Dec; 12(4):259-62. PubMed ID: 23279149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation with ramelteon to achieve remission in geriatric major depression.
    Furuya M; Kunishige K; Miyaoka T; Wake R; Liaury K; Sadakuni F; Horiguchi J
    Psychiatry Clin Neurosci; 2012 Feb; 66(1):81-2. PubMed ID: 22250616
    [No Abstract]   [Full Text] [Related]  

  • 11. [Melatonin, melatonin receptor agonists and tryptophan as sleep aids].
    Steinhilber D
    Pharm Unserer Zeit; 2007; 36(3):213-7. PubMed ID: 17555058
    [No Abstract]   [Full Text] [Related]  

  • 12. [Delirium, insomnia in hospitalization and ramelteon].
    Ito T
    Nihon Rinsho; 2012 May; 70(5):907-13. PubMed ID: 22620020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Let there be sleep--on time.
    Cardinali DP; Golombek DA
    Lancet; 2009 Feb; 373(9662):439-41. PubMed ID: 19054553
    [No Abstract]   [Full Text] [Related]  

  • 14. Addition of Suvorexant to Ramelteon Therapy for Improved Sleep Quality with Reduced Delirium Risk in Acute Stroke Patients.
    Kawada K; Ohta T; Tanaka K; Miyamura M; Tanaka S
    J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):142-148. PubMed ID: 30322756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin and Melatonin Agonists as Adjunctive Treatments in Bipolar Disorders.
    Geoffroy PA; Etain B; Franchi JA; Bellivier F; Ritter P
    Curr Pharm Des; 2015; 21(23):3352-8. PubMed ID: 26088111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ramelteon: a melatonin receptor agonist for the treatment of insomnia.
    Devi V; Shankar PK
    J Postgrad Med; 2008; 54(1):45-8. PubMed ID: 18296808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ramelteon: application withdrawn. Ramelteon in insomnia: withdrawal of marketing application in patients' best interests.
    Prescrire Int; 2009 Jun; 18(101):114. PubMed ID: 19639675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Cluster Headache Responsive to Ramelteon, a Selective Melatonin MT1/MT2 Receptor Agonist.
    Imai N
    Intern Med; 2016; 55(17):2483-5. PubMed ID: 27580554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ramelteon (rozerem) a novel approach for insomnia treatment.
    Laustsen G; Andersen M
    Nurse Pract; 2006 Apr; 31(4):52-5. PubMed ID: 16607213
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of Administration of Ramelteon, a Melatonin Receptor Agonist, on the Duration of Stay in the ICU: A Single-Center Randomized Placebo-Controlled Trial.
    Nishikimi M; Numaguchi A; Takahashi K; Miyagawa Y; Matsui K; Higashi M; Makishi G; Matsui S; Matsuda N
    Crit Care Med; 2018 Jul; 46(7):1099-1105. PubMed ID: 29595562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.